EMBC vs NEM · P/E 12, rev $1.08B vs P/E 14, rev $13.43B
Embecta Corp (EMBC) versus Newmont Goldcorp Corp (NEM) — a side-by-side from cached financials, not a winner call.
Embecta Corp (EMBC) is a medical instruments & supplies company listed on US.
Newmont Goldcorp Corp (NEM) is a gold company listed on NYSE.
Latest reported EMBC revenue for 2025-09-30 was $1.08B. Net income was $95.4M. Revenue was down 3.8% from 2024-09-30 to 2025-09-30. EMBC currently screens at market cap $609.6M and trailing P/E 11.7.
Latest reported NEM revenue for 2026-06-30 was $13.43B. Net income was $5.46B. Revenue was up 83.7% from 2026-03-31 to 2026-06-30. NEM currently screens at market cap $112.81B and trailing P/E 13.7.
EMBC currently screens at market cap $609.6M and trailing P/E 11.7. NEM currently screens at market cap $112.81B and trailing P/E 13.7.
Not investment advice. Open the EMBC and NEM stock pages for the full models.
Not investment advice.